Saini Bhawna, Agarwal Arohi, Singh Gagan, Jayachandran Sreejith, Jain Samyak
Clinical Pharmacology and Therapeutics, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Pharmacy Practice, Teerthanker Mahaveer College of Pharmacy, Moradabad, IND.
Cureus. 2024 Jul 11;16(7):e64341. doi: 10.7759/cureus.64341. eCollection 2024 Jul.
Angioedema is a non-pitting edema that involves the subcutaneous and submucosal layers of the face, lips, neck, oral cavity, larynx, and gut. It may become life-threatening when it involves tissues of the larynx. Angioedema can be triggered by exposure to drugs such as angiotensin-converting enzyme inhibitors (ACE inhibitors), opioid drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Tramadol is an opioid analgesic medication that may also induce angioedema, but the incidence of tramadol-induced angioedema is very rare in literature to date. It has been postulated that tramadol may cause fatal angioedema in the presence of underlying diseases such as systemic lupus erythematosus (SLE) or concomitant drugs such as NSAIDs. We describe the case of a patient with SLE who experienced fatal angioedema following tramadol intake.
血管性水肿是一种非凹陷性水肿,累及面部、嘴唇、颈部、口腔、喉部和肠道的皮下及黏膜下层。当累及喉部组织时,可能会危及生命。血管性水肿可由接触药物引发,如血管紧张素转换酶抑制剂(ACE抑制剂)、阿片类药物和非甾体抗炎药(NSAIDs)。曲马多是一种阿片类镇痛药物,也可能诱发血管性水肿,但迄今为止,曲马多诱发血管性水肿的发生率在文献中非常罕见。据推测,在存在系统性红斑狼疮(SLE)等基础疾病或服用NSAIDs等伴随药物的情况下,曲马多可能导致致命的血管性水肿。我们描述了一例SLE患者在服用曲马多后发生致命血管性水肿的病例。